Literature DB >> 4944

Purification of a catecholamine-rich fraction with prolactin release-inhibiting factor (PIF) activity from porcine hypothalami.

A V Schally, A Dupont, A Arimura, J Takahara, T W Redding, J Clemens, C Shaar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 4944     DOI： 10.1530/acta.0.0820001

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN： 0001-5598


× No keyword cloud information.
  6 in total

1.  Disorders of prolactin secretion.

Authors:  M O Thorner
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1976

Review 2.  Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.

Authors:  M F Scanlon; M Pourmand; A M McGregor; M D Rodriguez-Arnao; K Hall; A Gomez-Pan; R Hall
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

3.  Diethylstilbestrol potentiation of the dopamine-elicited formation of adenosine 3',5'-monophosphate in incubated male rat hypothalamus.

Authors:  B A Weissman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

4.  Bromocriptine--fact or expensive fancy.

Authors: 
Journal:  Br Med J       Date:  1977-04-02

5.  Isolation and characterization of two peptides with prolactin release-inhibiting activity from porcine hypothalami.

Authors:  A V Schally; J G Guoth; T W Redding; K Groot; H Rodriguez; E Szonyi; J Stults; K Nikolics
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

6.  Evidence that clomethiazole interacts with the macromolecular GABA A-receptor complex in the central nervous system and in the anterior pituitary gland.

Authors:  M Vincens; A Enjalbert; K G Lloyd; J J Paillard; F Thuret; C Kordon; P Lechat
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.